HOME >> BIOLOGY >> NEWS
Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University

Snowmass, Co. (September 10, 2004) - Inflammatory Bowel Diseases, comprised of Crohn's Disease and ulcerative colitis, are for the most part incurable and their causes are still unknown. About 1 million Americans suffer from IBD and research around the world on new therapeutic strategies against IBD is being reported at a conference sponsored by the American Physiological Society.

On one thing most researchers agree on about IBD: it's very complex. And though it might seem obvious that treating a complex disease might take more than one agent, use of combination therapy hasn't been discussed much in relation to IBD.

Now separate groups working in Houston/Boston and Jerusalem have considered the implications of combination therapy in IBD. They are presenting their papers at the APS conference.

Intestinal Lactobacillus reuteri-based combination therapy directly modulates mucosal pro-inflammatory cytokine production in IL-10 deficient mice.

Probiotics and commensal bacteria represent likely sources for novel therapeutic strategies in inflammatory bowel diseases, and have become increasingly interesting to researchers. Indeed, some probiotic therapy agents are thought to be nearing the clinical trial stage. It is well-known that the human (and animal) gut is full of mostly beneficial bacteria. In IBD and other diseases researchers have taken an approach that reintroduces these positive bacteria, allow them to repopulate the gut and quite often they produce their own anti-inflammatory chemicals. One of the major such "bugs" is the genus Lactobacillus.

The research reported below was carried by James Versalovic and Jeremy Andrew Pena at the Baylor College of Medicine/Texas Children's Hospital, Houston, Texas, and by Arlin B. Rogers, Zhongming Ge and James G. Fox at the Division of Comparative Medicine at Massachusetts Institute of Technology, Cambridge, Mass.

Probiotics have demonstrated efficacy in treating patients
'"/>


10-Sep-2004


Page: 1 2 3

Related biology news :

1. Winning combination to build bone density in children
2. Complex cells likely arose from combination of bacterial and extreme-microbe genomes
3. Researchers zero in on new drug combination strategy
4. IUB researchers to investigate genetic recombinations causes and consequences
5. Mutated protein combination tied to excessive sugar production
6. Clinical study reports findings of combination therapy with DOXIL
7. Novel COX-2 combination treatment may reduce colon cancer risk
8. Drug combination increases life span of mice with ALS
9. A combination of zinc and vitamin A may restore night vision in pregnant Nepalese women
10. Alcohol and thiamine deficiency together: a dangerous combination?
11. Inter-Element Recombination Between Retrotransposons May Be Strategy For Evolution Of Viruses Like HIV

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/9/2019)... ... March 07, 2019 , ... A firm believer in causes ... & Lymphoma Society (LLS). This donation will help fund not only research to find ... families. , “We are always on the lookout for ways to make a ...
(Date:3/9/2019)... ... March 09, 2019 , ... ... hM4Di ligands – exciting compounds for scientists studying GPCR and DREADD signalling. Hello ... and the National Institute of Neurological Disorders and Stroke, both institutes of the ...
(Date:2/27/2019)... ALAMEDA, Calif. (PRWEB) , ... February 27, 2019 , ... ... today announced that it has received a National Cancer Institute grant for further development ... of 9 months, with clinical support from the lab of Dr. Omar Mian at ...
Breaking Biology News(10 mins):
(Date:3/12/2019)... ... March 12, 2019 , ... Diagenode, a leading ... its third generation long-fragment DNA shearing innovation, the Megaruptor 3. This new solution ... automated processing, and the ability to process up to 8 samples simultaneously ...
(Date:3/9/2019)... ... March 07, 2019 , ... ACEA ... the development and commercialization of high performance, cutting-edge cell analysis platforms for life ... with GLP-certified expertise in cardiovascular pharmacology and electrophysiology, are announcing a partnership to ...
(Date:3/5/2019)... , ... March 05, 2019 , ... ... cold chain engineering firm with regulatory filing authorities, logistics network experts, and experienced ... to initiate its participation in the Inc. Verified Profile program, Inc. editors independently ...
(Date:2/27/2019)... ... 2019 , ... Superior Controls, Inc., a leading Life Sciences ... on both the east and west coasts, today announced that employee Nathan Sandmaier, ... Sandmaier, a senior project engineer, joins Taggart McCormick, P.E., Anthony Whitesell, P.E., and ...
Breaking Biology Technology:
Cached News: